Clinical Trials Directory

Trials / Conditions / Allogeneic Disease

Allogeneic Disease

7 registered clinical trials studyying Allogeneic Disease — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRadioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
NCT07157514
Actinium PharmaceuticalsPhase 2 / Phase 3
Not Yet RecruitingWharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis
NCT05855707
Central Hospital, Nancy, FrancePhase 1
RecruitingAPOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation
NCT05579678
University of Alberta—
CompletedCancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT
NCT04966156
University Health Network, TorontoN/A
UnknownTo Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Dise
NCT03371667
Assistance Publique - Hôpitaux de ParisPhase 3
CompletedMethyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic
NCT03343834
Assistance Publique - Hôpitaux de ParisN/A
WithdrawnA Pilot Study of the Feasibility of Setting up a Logbook for Allogeneic Haematopoietic Stem Cell Patients at t
NCT03149952
Centre Hospitalier Universitaire, AmiensN/A